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ABSTRACT 25	
Diphtheria is a debilitating disease caused by toxigenic Corynebacterium diphtheriae 26	
strains and has been effectively controlled by the toxoid vaccine, yet several recent outbreaks 27	
have been reported across the globe. Moreover, non-toxigenic C. diphtheriae strains are 28	
emerging as a major global health concern by causing severe pharyngitis and tonsillitis, 29	
endocarditis, septic arthritis and osteomyelitis. Molecular epidemiological investigations 30	
suggest the existence of outbreak-associated clones with multiple genotypes circulating 31	
around the world. Evolution and pathogenesis appears to be driven by recombination as 32	
major virulence factors, including the tox gene and pilus gene clusters, are found within 33	
genomic islands that appear to be mobile between strains. The number of pilus gene clusters 34	
and variation introduced by gain or loss of gene function correlate with the variable adhesive 35	
and invasive properties of C. diphtheriae strains. Genomic variation does not support the 36	
separation of C. diphtheriae strains into biovars which correlates well with findings of studies 37	
based on multilocus sequence typing. Genomic analyses of a relatively small number of 38	
strains also revealed a recombination driven diversification of strains within a sequence type 39	
and indicate a wider diversity among C. diphtheriae strains than previously appreciated. This 40	
suggests that there is a need for increased effort from the scientific community to study C. 41	
diphtheriae to help understand the genomic diversity and pathogenicity within the population 42	
of this important human pathogen. 43	
 44	
1. Introduction 45	
Toxigenic Corynebacterium diphtheriae are responsible for diphtheria in humans, a 46	
toxin-mediated disease of the upper respiratory tract which is generally characterized by the 47	
presence of an inflammatory pseudomembrane on the tonsils, oropharynx and pharynx 48	
causing sore throat, high temperature and potentially death (Hadfield et al., 2000). The toxin 49	
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is encoded by the tox gene within the lysogenised β-corynephage (Sangal and Hoskisson, 50	
2014a) and can be effectively controlled by the diphtheria toxoid vaccine (Baxter, 2007). The 51	
cases of diphtheria were significantly reduced following the global immunization initiative 52	
(Galazka, 2000). Yet in the 1990s, the Newly Independent States (largely Former Soviet 53	
Union) observed the largest outbreaks of Diphtheria since the introduction of mass 54	
vaccination (Vitek & Wharton, 1998). In addition, there is still considerable morbidity and 55	
mortality around the world caused by this organism (www.WHO.int) and we need to remain 56	
vigilant. 57	
Non-toxigenic C. diphtheriae strains (those that lack the tox gene) are now emerging 58	
as the cause of significant disease, especially invasive infections such as endocarditis, septic 59	
arthritis and osteomyelitis (Barakett et al., 1993; Belko et al., 2000; Edwards et al., 2011; 60	
Farfour et al., 2012; Patey et al., 1997; Poilane et al., 1995; Romney et al., 2006; Tiley et al., 61	
1993). There is also the potential for C. diphtheriae to cause skin infections which result in 62	
cutaneous diphtheria across the globe in patients with varying vaccination status and travel 63	
histories (Gordon et al., 2011; Romney et al., 2006; Huhulescu et al., 2014; Cassir et al., 64	
2015; Nelson et al., 2016). These infections are often associated with travel to C. diphtheriae 65	
prevalent endemic areas (FitzGerald et al., 2015; Lindhusen-Lindhe et al., 2012; May et al., 66	
2014). More recently, non-toxigenic tox gene-bearing strains (NTTB) have also been reported 67	
from Europe (Zakikhany et al., 2014). These NTTB strains possess the tox gene, however 68	
mutation (a nucleotide deletion or disruption by an insertion sequence) in the A-subunit of the 69	
gene prevents expression (Zakikhany et al., 2014). These strains pose a potential threat to 70	
public through genetic reversion resulting in toxin production. Moreover, carriage of non-71	
toxigenic strains in healthy individuals, as part of the normal upper respiratory tract flora is 72	
poorly understood, but has the potential to act as a reservoir of bacteria that can undergo 73	
phage-conversion and dissemination. 74	
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C. diphtheriae strains have historically been subdivided into the four biovars - gravis, 75	
intermedius, mitis and belfanti (Funke et al., 1997; Goodfellow et al., 2012). However, this 76	
biochemical differentiation appears to be dependent on technical capabilities of the laboratory 77	
and is unsupported by genomic analysis (Sangal et al., 2014a). This view is also supported by 78	
the quality assurance (Elek) tests for diphtheria diagnostics by the European diphtheria 79	
surveillance network (EDSN) where several participating laboratories could not correctly 80	
identify these biovars, particularly biovars intermedius and belfanti (Both et al., 2014; Neal 81	
and Efstratiou, 2009). 82	
Related pathogenic corynebacteria including Corynebacterium ulcerans and 83	
Corynebacterium pseudotuberculosis generally cause zoonotic infection in humans (Peel et 84	
al., 1997; Taylor et al., 2010; Wagner et al., 2011; Sangal et al., 2014b) whereas C. 85	
diphtheriae appears to be largely human specific. Recent reports highlight potential host 86	
jump of C. diphtheriae to and from domesticated and wild animals (Sing et al., 2015; 87	
Zakikhany et al., 2014). This is particularly important as the tox gene carrying β-corynephage 88	
is able to lysogenize all three species Ð C. diphtheriae, C. ulcerans and C. pseudotuberculosis 89	
and the promiscuous nature of the corynephage may result in human outbreaks of diphtheria 90	
and diphtheria-like diseases caused by non-C. diphtheriae strains.  91	
Here we aim to provide an overview of global epidemiology and evolutionary 92	
dynamics of C. diphtheriae in the light of recent work in the field, with particular emphasis 93	
on the impact of whole genome sequencing in understanding the evolution and pathogenicity 94	
of different C. diphtheriae strains. 95	
 96	
2. C. diphtheriae is genetically diverse 97	
Despite an estimated 86% global coverage of the vaccine, 7,321 cases of diphtheria 98	
were reported in 2014, mainly from the developing countries (www.WHO.int). A diphtheria 99	
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epidemic in the former Soviet Union in the 1990s resulted in >157,000 cases claiming ~5000 100	
lives (Dittmann et al., 2000). Yet, this pathogen is not under control, and the have been 101	
multiple outbreaks in different countries since 2000 including Colombia (Landazabal et al., 102	
2001), India (Parande et al., 2014; Saikia et al., 2010), Norway (Rasmussen et al., 2011), 103	
Nigeria (Besa et al., 2014), Thailand (Wanlapakorn et al., 2014), and more recently in Brazil 104	
(Santos et al., 2015), Laos (Nanthavong et al., 2015) and Indonesia (Hughes et al., 2015). 105	
The molecular epidemiology and diversity of C. diphtheriae has been investigated 106	
using a number of genotyping approaches including ribotyping, amplified fragment length 107	
polymorphism (AFLP), pulse-field gel electrophoresis (PFGE), random amplified 108	
polymorphic DNA (RAPD), clustered regularly interspaced short palindromic repeat 109	
(CRISPR) based spoligotyping and multilocus sequence typing (MLST) (Bolt et al., 2010; 110	
Damian et al., 2002; De Zoysa et al., 2008; Grimont et al., 2004; Kolodkina et al., 2006; 111	
Mokrousov et al., 2007; Mokrousov et al., 2005; Mokrousov et al., 2009; Titov et al., 2003). 112	
Most of the typing approaches exhibited some degree of correspondence (Damian et al., 113	
2002; De Zoysa et al., 2008; Kolodkina et al., 2006; Titov et al., 2003). Ribotyping was 114	
found to be more discriminatory than PFGE and AFLP (De Zoysa et al., 2008) and was the 115	
gold standard for genotyping C. diphtheriae prior to the introduction of a robust MLST 116	
approach (Bolt et al., 2010; Grimont et al., 2004). The main Ribotyping scheme adhered to is 117	
that of Grimont et al., (2004) with each ribotype being allocated a geographical name based 118	
on the location of isolation; however, some previous studies followed an arbitrary 119	
nomenclature to represent different ribotypes. Ribotyping identified 34 ribotypes among 167 120	
C. diphtheriae strains from Romania, the Russian Federation and the Republic of Moldova 121	
(Damian et al., 2002). The strains belonging to two ribotypes, C1 and C5 were predominant 122	
in Russia and Moldova whereas ribotypes C3 and C7 were isolated more frequently in 123	
Romania (Damian et al., 2002). The majority of C. diphtheriae strains were found to belong 124	
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to ribotypes D1 and D4 in Belarus (Titov et al., 2003). Remarkably, the distribution of 125	
ribotypes was found to alter between 1996 and 2005 (Kolodkina et al., 2006). Interestingly, 126	
this may be the result of increased vaccination in these areas following the outbreaks, perhaps 127	
indicating some level of vaccine-driven population selection in C. diphtheriae. Overall, all 128	
these studies identified prevalent clones associated with different outbreaks, but also found 129	
that multiple genotypes were circulating within different continents, suggesting great 130	
diversity of C. diphtheriae strains within the human population (Damian et al., 2002; De 131	
Zoysa et al., 2008; Kolodkina et al., 2006; von Hunolstein et al., 2003). 132	
CRISPR based spoligotyping offered additional resolution within these ribotypes and 133	
was successfully used to characterize outbreak-associated strains from countries of former 134	
Soviet Union (Mokrousov, 2013; Mokrousov et al., 2005; Mokrousov et al., 2009). The 135	
epidemic strains from Russia that belonged to two ribotypes (Sankt-Peterburg and Rossija) 136	
were subdivided into 45 spoligotypes (Mokrousov, 2013; Mokrousov et al., 2007; 137	
Mokrousov et al., 2005). Due to the higher diversity within ribotype Sankt-Peterburg, it was 138	
proposed to have evolved prior to the emergence ribotype Rossija, indicating that new strains 139	
are emerging regularly within this species (Mokrousov, 2013). 140	
While most genotypic approaches are focused on outbreak characterization and high 141	
resolution strain discrimination, MLST is more appropriate to investigate long-term 142	
evolutionary dynamics and has been applied to a number of microorganisms prior to the 143	
emergence of cost effective genome sequencing (Maiden, 2006). A robust MLST scheme was 144	
developed for C. diphtheriae in 2010 and sequence types (STs) were shown to be consistent 145	
with the previously determined C. diphtheriae ribotypes and offered higher resolution in most 146	
cases (Bolt et al., 2010). One important feature of the MLST studies was that they revealed a 147	
lack of correlation between the STs and the widely used biovar system and also showed no 148	
correlation with the severity of the disease caused by different strains (Bolt et al., 2010; 149	
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Farfour et al., 2012). While some eBURST groups, the so called clonal complexes, were 150	
found to be associated with certain countries, others were reported from multiple continents, 151	
indicating wide dissemination of strains (Bolt et al., 2010). MLST diversity has grown since 152	
2010 and the data for 384 reference STs is available from the MLST website 153	
(http://pubmlst.org/cdiphtheriae/; accessed in November 2015). A total of 115 of these STs 154	
formed 11 major eBURST groups where the predicted founder had three or more single locus 155	
variants (Fig. 1). However, some of these data belong to C. ulcerans strains and may also 156	
contain some erroneous submissions to the database by the public. 157	
 More recently, whole genome sequences of 20 C. diphtheriae strains have been 158	
analysed (Cerdeno-Tarraga et al., 2003; Sangal et al., 2015; Sangal et al., 2014; Sangal et al., 159	
2012a, b; Trost et al., 2012), revealing the genetic diversity amongst and within the major 160	
STs. Approximately 60% of the genome appears to be functionally conserved within C. 161	
diphtheriae strains with 1,625 genes belonging to the core genome (Sangal et al., 2015). 162	
However, enough diversity has accumulated within the core genes to allow discrimination of 163	
most C. diphtheriae strains from each other. Strains within STs appear to show close 164	
relationships indicating the robust nature of the MLST approach (Fig. 2; Bolt et al., 2010; 165	
Sangal et al., 2015). Similar groupings were also obtained from the genome-wide single 166	
nucleotide polymorphism analysis (SNPs; Sangal et al., 2014). The accessory genome varied 167	
greatly among C. diphtheriae strains (Sangal et al., 2015) even when a relatively small 168	
number of genomes was considered (14 known STs; Fig. 1). This indicates that most of the 169	
C. diphtheriae diversity remains to be discovered and will be crucial in our understanding of 170	
the molecular epidemiology, global transmission and carriage of this pathogen. 171	
 172	
3. Evolutionary dynamics 173	
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Despite the global emergence of non-toxigenic strains and multiple recent outbreaks 174	
caused by C. diphtheriae, little is known about the evolutionary dynamics of this pathogen 175	
and most of the current understanding comes from the genomic analyses. MLST analyses 176	
indicated that there is significant recombination within C. diphtheriae populations (Bolt et al., 177	
2010). Recombination plays an important role in bacterial evolution and is often linked to the 178	
increased virulence in some strains (Joseph et al., 2011; Suarez et al., 2004; Wirth et al., 179	
2006). Indeed, the primary niche of C. diphtheriae in humans is the upper respiratory tract 180	
which is a hot-bed of horizontal gene transfer between bacterial strains (Marks et al., 2012). 181	
A total of 57 genomic islands have been reported in C. diphtheriae and the 182	
distribution was found to vary significantly between strains (Trost et al., 2012). The genomic 183	
islands can be horizontally acquired from other bacteria, suggesting that recombination is 184	
shaping the current genetic diversity in C. diphtheriae. Some of the genomic islands carried 185	
phage associated genes while others harboured the genes that encode proteins for different 186	
cellular activities including siderophore biosynthesis and transport, degradation of 187	
polysaccharides and hydrocarbon derivatives such as 3-hydroxyphenylpropionic acid, 188	
antibiotic and heavy metal resistance (Trost et al., 2012). The major virulence factor of C. 189	
diphtheriae, the tox gene, is carried on a bacteriophage that can also move between strains, 190	
resulting in phage conversion (Barksdale and Pappenheimer, 1954; Freeman, 1951; Sangal 191	
and Hoskisson, 2014). Genomic islands carrying different spa operons introduced the 192	
variation in the ability of C. diphtheriae strains to form pili and interact with the host. These 193	
spa operons harbour genes encoding subunits of different types of pili and the gain or loss of 194	
the function of these genes correlate to the number and expression of pili on the cell surface 195	
(Ott et al., 2010; Chang et al., 2011; Trost et al., 2012).  196	
Approximately one-third of the C. diphtheriae genome encodes accessory genes that 197	
vary widely between strains (Sangal et al., 2015). The strains within individual STs differed 198	
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from each other by the presence or absence of up to 290 genes, many of which are present on 199	
the genomic islands (Sangal et al., 2015). These observations indicate likely differences in 200	
recombination frequencies between C. diphtheriae strains. The frequencies of recombination 201	
may vary widely between different strains within a species (Sangal et al., 2010), and may 202	
reflect the difference in strain propensities for acquiring foreign DNA, which may result in 203	
variation in pathogenicity of strains. Restriction-modification systems, bacteriophage defence 204	
systems and CRISPR-Cas systems are major barriers to recombination that have been 205	
reported in the genomes of C. diphtheriae strains (Hoskisson & Smith, 2007; Sangal et al., 206	
2013). 207	
Genomic analyses of C. diphtheriae strains revealed the presence of two types of 208	
CRISPR-Cas systems in three different configurations (Sangal et al., 2013). These systems 209	
are comprised of CRISPR-associated proteins (Cas proteins encoded by cas genes) and 210	
CRISPR arrays of short spacer sequences acquired from invading bacteriophages or plasmids 211	
that are separated by repeat sequences. These arrays are transcribed into crRNA that 212	
recognizes the invasion by the same nucleic acids and activate their cleavage by Cas 213	
ribonucleoprotein complex (Marraffini, 2015). The acquisition of each spacer sequence 214	
represents a unique evolutionary event, an encounter of the bacterial cell with the 215	
bacteriophage or plasmid that may be unique to particular environment. 216	
The majority of C. diphtheriae strains carried a type II-C CRISPR-Cas system, 217	
however this was replaced by a type I-E-a in some strains or vice versa (Sangal et al., 2013). 218	
A few strains with a type II-C system possessed an additional CRISPR-Cas system, type I-E-219	
b, at a different location in the genome. The variation in the G+C content and the 220	
phylogenetic analyses of cas1 gene, along with the direct repeat sequences in the CRISPR 221	
arrays suggest three independent horizontal acquisitions of these CRISPR-Cas systems by C. 222	
diphtheriae. Most of the spacer sequences are unique to CRISPR arrays in different strains, 223	
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suggesting that these strains evolved in different environments and encountered a range of 224	
different bacteriophages or plasmids (Sangal et al., 2013). Some strains were found to share 225	
spacer sequences at the distal end of the array, which may represent common strain ancestry 226	
or abundance of a particular foreign DNA type (bacteriophages/plasmids). The type of 227	
CRISPR-Cas systems and most of the spacer sequences in the arrays were shared between 228	
individuals of the same ST, which is consistent with their evolution from a recent common 229	
ancestor. These results also support CRISPR loci as useful molecular markers for strain 230	
identification and epidemiological studies (Mokrousov, 2013; Mokrousov et al., 2007). 231	
Overall, the genomic and spacer diversities found in C. diphtheriae strains indicate 232	
unique evolutionary trajectories for different C. diphtheriae strains after they separated from 233	
their last common ancestor. However, no clear geographic or temporal association of C. 234	
diphtheriae strains has been reported. Interestingly, this may simply reflect a sampling bias, 235	
as available genomes reflect <10% of the current C. diphtheriae diversity observed from 236	
MLST analysis (Fig. 1). These data highlight the need to expand the genome sequencing 237	
effort for this species to fully understand the evolutionary dynamics of this pathogen. 238	
 239	
4. Genetic basis of biochemical differentiation 240	
The biochemical differentiation of C. diphtheriae strains into biovars is complex and 241	
unreliable, however for historical reasons it is still routinely followed by reference labortories 242	
(Both et al., 2014; Neal and Efstratiou, 2009; Sangal et al., 2014). The key characteristics 243	
include lipophilism of biovar intermedius strains - the need lipids for optimal growth and the 244	
formation of small gray or translucent colonies on agar plates (Funke et al., 1997). The strains 245	
of other biovars generally form large white or opaque colonies. The strains of biovar belfanti 246	
can not reduce nitrate and only biovar gravis strains seem to definitely utilize glycogen and 247	
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starch as carbon sources (Efstratiou et al., 2000; Efstratiou and George, 1999; Goodfellow et 248	
al., 2012). 249	
Comparative genomic analyses identified that four genes involved in carbohydrate 250	
metabolism are absent or are pseudogenes in the intermedius strain (Sangal et al., 2014), 251	
potentially suggesting that this biovar may have compromised abilities to effectively use 252	
carbohydrates as the energy source and require alternate carbon source such as lipids, for 253	
optimal growth in the host. We have previously highlighted an insertion at the 3Õ end of narJ 254	
gene in the only sequenced belfanti genome, that results in an extended coding sequence in 255	
comparison to its homolog DIP0498 in NCTC 13129 (Sangal et al., 2014). However, the 256	
annotation of strain NCTC 13129 has recently been revised (GenBank accession number: 257	
NC_002935.2; new locus tag for DIP0498: DIP_RS13825) and the protein sequence of narJ 258	
is of the same length as observed in belfanti. Therefore, genetic basis of the belfanti strains 259	
not being able to reduce nitrate remains unclear. The phylogenomic analyses of core genome, 260	
accessory genome and genome-wide SNPs revealed an absence of a biovar specific grouping. 261	
Therefore, the biochemical seperation of C. diphtheriae into the traditional biovars is not 262	
supported by genomic diversityand is unsuitable for modern epidemiological studies (Sangal 263	
et al., 2015; Sangal et al., 2014; Trost et al., 2012). Genome sequencing results are consistent 264	
with the MLST phylogeny where the major C. diphtheriae lineage included strains from all 265	
four biovars (Bolt et al., 2010). However, a smaller second befanti-specific lineage can be 266	
observed from the MLST analyses which is not detected in the genomic study, potentially 267	
because the genome sequence of only one strain for each of the biovars belfanti and 268	
intermedius is available that highlights a clear need for more strains of these biovars to be 269	
sequenced.  270	
 271	
5. Variation in pathogenicity and invasive strains  272	
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C. diphtheriae is considered a paradigm of mucosal pathogenicity, with much of the 273	
research focused on toxin production and pseudomembrane formation, almost to the neglect 274	
of studying other virulence mechanisms, such that the discovery of invasive strains of C. 275	
diphtheriae was a surprise to researchers. The tox gene, encoding the diphtheria toxin, is 276	
harboured on the genome of the β-corynephage, which integrates into C. diphtheriae genome 277	
between duplicated arginine tRNA
 
genes (Sangal and Hoskisson, 2014; Trost et al., 2012). 278	
Only one prophage is present in most toxigenic strains, with the exception of strain PW8 279	
where two copies of corynephage ω
tox+ 
is found (Sangal and Hoskisson, 2014; Trost et al., 280	
2012). While the nucleotide sequence of different corynephages show high levels of 281	
diversity, the sequence of the tox gene is highly conserved and also reflects the efficacy of the 282	
toxoid vaccine. The transcription of tox gene is controlled by the DtxR regulon, which is a 283	
key determinant for iron homeostasis (De Zoysa et al., 2005; Fourel et al., 1989). Iron is 284	
involved in a number of cellular activities and the induction of toxin in low iron availability 285	
might help pathogens to compete with the host for iron (Ganz and Nemeth, 2015; Trost et al., 286	
2012) or liberate iron through killing of host cells. The gene composition of DtxR regulons in 287	
different C. diphtheriae strains may vary due to gain or loss of the genes that may affect the 288	
iron supply to the bacterial cell and hence, the expression of the tox gene (Litwin and 289	
Calderwood, 1993; Trost et al., 2012). 290	
Non-toxigenic C. diphtheriae strains by definition do not contain the tox carrying β-291	
corynephage, but do vary in their abilities to adhere to host cells, intracellular viability and 292	
their ability to stimulate cytokine production by the host immune system which may 293	
influence the severity of the disease due to infection (Bertuccini et al., 2004; Hirata et al., 294	
2002; Peixoto et al., 2014; Puliti et al., 2006). These strains differ from each other in the 295	
presence and organisation of different pilus gene clusters, spaA, spaD and spaH (Sangal et 296	
al., 2015; Trost et al., 2012). Two pilus gene clusters, spaD and spaH, were present in four C. 297	
13	
	
diphtheriae strains that exhibited different adhesive and invasive properties. Interestingly, the 298	
spaA operon was only present in the two strains with higher adhesion to pharyngeal D562 299	
cell lines (Ott et al., 2010; Sangal et al., 2015). SpaA pili have been shown to interact with 300	
the pharyngeal epithelial cells and SpaD and SpaH with the laryngeal and lung epithelial cell 301	
types (Mandlik et al., 2007; Reardon-Robinson and Ton-That, 2014) suggesting niche 302	
specialised roles for specific pilus types. However, some genes were found to be pseudogenes 303	
in these clusters (Sangal et al., 2015), for example, srtB gene that encodes sortase for 304	
incorporation of SpaE into the SpaD subunit of SpaD-type pili, spaG encoding a subunit of 305	
SpaH-type pili and spaB encoding pilus base subunit of SpaA-type pili were pseudogenes in 306	
strains ISS 4060, ISS 3319 and ISS 4746, respectively (Reardon-Robinson and Ton-That, 307	
2014; Sangal et al., 2015). In addition, a gene spaF that encodes surface anchored fimbrial 308	
subunit of spaD-type pili was pseudogenitised both in ISS 4746 and ISS 4749. Strain ISS 309	
4749 with two intact gene clusters (SpaA and SpaH) exhibited highest number of pili at the 310	
cell surface and highest adhesion to the cell lines when compared to ISS 3319 (SpaD gene 311	
cluster) and ISS 4746 (SpaH gene cluster) with only one intact gene cluster (Bertuccini et al., 312	
2004; Ott et al., 2010; Sangal et al., 2015). Although SpaH gene cluster appears to be fully 313	
functional in ISS 4060 strain, no surface pili were observed, suggesting there may be 314	
variation in the levels of gene expression. However, adhesive properties of this strain were 315	
comparable to ISS 3319 (Bertuccini et al., 2004; Ott et al., 2010; Sangal et al., 2015). 316	
Therefore, the macromolecular surface structure and cell adhesion properties generally 317	
correlate to the presence of pilus gene clusters in C. diphtheriae and expression of these 318	
genes may be subject to unknown gene regulation mechanisms. 319	
ISS 4746 and ISS 4749 were also shown to induce higher cytokine (IL-1 and IL-6) 320	
production and caused higher incidences and severity of arthritis in mice in comparison to 321	
ISS 3319 (Puliti et al., 2006). In addition to the membrane associated proteins, comparative 322	
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genomic analyses revealed a variation in predicted secreted proteins including lipoproteins 323	
and non-classical secreted proteins among these strains, which may be associated with the 324	
variation in the degree of pathogenesis (Sangal et al., 2015). Most of these proteins are 325	
hypothetical and a molecular characterization of these proteins might further improve 326	
understanding of the mechanisms of adhesion, invasion and immune induction in C. 327	
diphtheriae. 328	
 329	
6. Conclusions 330	
C. diphtheriae is still a major human pathogen, with multiple contemporary outbreaks 331	
around the world. Moreover, non-toxigenic strains are beginning to cause significant invasive 332	
disease in patients. Genomic analyses not only identified potential genes involved in 333	
adhesive, invasive and virulence characteristics of C. diphtheriae strains but also highlighted 334	
the impact of horizontal gene transfer in acquisition of these genes. These analyses also raise 335	
concerns about the use of biochemical separation of C. diphtheriae strains into biovars in 336	
clinics as a biovar encompasses genetically distinct strains. The evolutionary dynamics and 337	
the global diversity in C. diphtheriae are poorly characterized, clearly emphasizing the need 338	
of a community-based genome sequencing program that will improve the understanding of 339	
global transmission and local adaptation and will facilitate the development of effective 340	
surveillance policies and preventive strategies, amid multiple ongoing outbreaks. It will also 341	
inform on future vaccine development, perhaps to augment existing toxoid-based vaccines 342	
with universal surface proteins from C. diphtheriae which may be more effective in reducing 343	
carriage and the invasive diseases caused by non-toxigenic strains. 344	
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Figure Legends 604	
Fig. 1. An eBURST diagram from the MLST profiles of reference STs from the MLST 605	
website (http://pubmlst.org/cdiphtheriae/). The predicted founder STs are shown in blue and 606	
co-founder STs are shown in yellow. Single locus variants (SLVs) are connected to each 607	
other and major groups where predicted founder has three or more SLVs are labelled. The 608	
known STs for C. ulcerans are shown in cyan. ST with some genome sequenced strains are 609	
encircled in red. 610	
 611	
Fig. 2. A phylogenetic tree from the core genome of C. diphtheriae (adapted from Sangal et 612	
al., 2015). ST designations are mapped on the tree in parentheses, if known.  The strains 613	
biovars gravis, mitis, belfanti and intermedius are labelled in red, green, purple and blue, 614	
respectively. 615	
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